Cancer Therapeutics, Inc. is a biotechnology business incubator, focuses on disruptive treatments using nanotechnology. The Company seeks out disruptive cancer research and technology opportunities to invest in, develop, and commercialize. It also seeks to co-develop drugs. In May 2009, the Company acquired 25% interest in NanoTherapies LLC (NanoTherapies). NanoTherapies’s products introduce technology into the treatment and detection of cancer through the use of calcium phosphate nanoparticles. These particles, about 350 times smaller than a human cell, provide safe way to transport drugs and imaging materials into diseased cells. NanoTherapies also owns all rights to manufacturing technologies required to produce pharmaceutical drugs at the scale and yield needed for commercial viability.